Skip to main content
S. 2952 117th Congress Senate

FDA Modernization Act of 2021

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to … Show full official titleShow less

Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.

Introduced: March 1, 2022 Introduced by: Rand Paul Republican · Kentucky See on congress.gov
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 7, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Oct 7, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action October 7, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

FDA Modernization Act of 2021

This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, computer modeling, and other human biology-based test methods.

 Related & companion bills 2
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 7

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 1st Quarter 2026 (Jan 1 - Mar 31)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 4th Quarter 2025 (Oct 1 - Dec 31)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 3rd Quarter 2025 (July 1 - Sep 30)
  • FARRAGUT PARTNERS LLP
    for ANIMAL WELLNESS ACTION · District of Columbia · 2nd Quarter 2025 (Apr 1 - June 30)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 7 filings →
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2952: FDA Modernization Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-S-2952/
MLA
"S. 2952: FDA Modernization Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2952/.
Bluebook (legal)
S. 2952, 117th Cong. (2026), https://openamerica.io/bill/117-S-2952/.
Markdown link
[S. 2952: FDA Modernization Act of 2021](https://openamerica.io/bill/117-S-2952/)
Report a problem